- Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas
-
Shin H, Sa JK, Bae JS, Koo H, Jin S, Cho HJ, Choi SW, Kyoung JM, Kim JY, Seo YJ, Joung JG, Kim NKD, Son DS, Chung J, Lee T, Kong DS, Choi JW, Seol HJ, Lee JI, Suh YL, Park WY, Nam DH
- KMID: 2501200
- Cancer Res Treat.
- 2020 Jan;52(1):41-50.
- doi: 10.4143/crt.2019.036
Purpose Targeted next-generation sequencing (NGS) panels for solid tumors have been useful in clinical framework for accurate tumor diagnosis and identifying essential molecular aberrations. However, most cancer panels have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth
-
Lee J, Shin YJ, Lee K, Cho HJ, Sa JK, Lee SY, Kim SH, Lee J, Yoon Y, Nam DH
- KMID: 2417889
- Cancer Res Treat.
- 2018 Jul;50(3):1009-1022.
- doi: 10.4143/crt.2017.315
PURPOSE: Glioblastoma (GBM) is classified as one of the most aggressive and lethal brain tumor. Great strides have been made in understanding the genomic and molecular underpinnings of GBM, which... -
- CITED
-
- Close
- SHARE
-
- Close
